Article
Mutational potentiality of stannous chloride: an important reducing agent in the Tc-99m-radiopharmaceuticals.
Mutation research - 7 Aug 1998
Cabral R E, Leitão A C, Lage C, Caldeira-de-Araújo A, Bernardo-Filho M, Dantas F J, Cabral-Neto J B
Abstract excerpt
Stannous chloride (SnCl2) is frequently used in nuclear medicine as a reducing agent to label many radiopharmaceutical products with technetium-99m (99mTc). The aim of the present paper was to study the role of DNA repair genes in the repair of SnCl2-induced damage, using mutant strains of Escherichia coli lacking one or more DNA repair genes. Our results suggest that the product of the xthA gene, exonuclease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
